ABT logo

Abbott Laboratories (ABT) EBIT

annual EBIT:

$7.23B-$73.00M(-1.00%)
December 31, 2024

Summary

  • As of today (April 18, 2025), ABT annual earnings before interest & taxes is $7.23 billion, with the most recent change of -$73.00 million (-1.00%) on December 31, 2024.
  • During the last 3 years, ABT annual EBIT has fallen by -$1.52 billion (-17.34%).
  • ABT annual EBIT is now -18.46% below its all-time high of $8.86 billion, reached on December 31, 2022.

Performance

ABT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly EBIT:

$2.08B-$7.00M(-0.34%)
December 31, 2024

Summary

  • As of today (April 18, 2025), ABT quarterly earnings before interest & taxes is $2.08 billion, with the most recent change of -$7.00 million (-0.34%) on December 31, 2024.
  • Over the past year, ABT quarterly EBIT has increased by +$121.00 million (+6.19%).
  • ABT quarterly EBIT is now -30.99% below its all-time high of $3.01 billion, reached on March 31, 2022.

Performance

ABT quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM EBIT:

$7.48B+$121.00M(+1.64%)
December 31, 2024

Summary

  • As of today (April 18, 2025), ABT TTM earnings before interest & taxes is $7.48 billion, with the most recent change of +$121.00 million (+1.64%) on December 31, 2024.
  • Over the past year, ABT TTM EBIT has increased by +$180.00 million (+2.47%).
  • ABT TTM EBIT is now -29.26% below its all-time high of $10.57 billion, reached on June 30, 2022.

Performance

ABT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ABT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.0%+6.2%+2.5%
3 y3 years-17.3%+6.2%+2.5%
5 y5 years+52.3%+6.2%+2.5%

ABT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.5%at low-31.0%+40.8%-29.3%+9.7%
5 y5-year-18.5%+52.3%-31.0%+214.4%-29.3%+82.2%
alltimeall time-18.5%+7128.0%-31.0%+176.8%-29.3%+540.1%

Abbott Laboratories EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$7.23B(-1.0%)
$2.08B(-0.3%)
$7.48B(+1.6%)
Sep 2024
-
$2.08B(+19.2%)
$7.36B(+3.4%)
Jun 2024
-
$1.75B(+10.8%)
$7.12B(-0.7%)
Mar 2024
-
$1.58B(-19.3%)
$7.16B(-1.9%)
Dec 2023
$7.30B(-17.6%)
$1.95B(+6.4%)
$7.30B(+7.0%)
Sep 2023
-
$1.84B(+2.3%)
$6.82B(-0.9%)
Jun 2023
-
$1.79B(+4.7%)
$6.88B(-9.1%)
Mar 2023
-
$1.72B(+16.4%)
$7.57B(-14.6%)
Dec 2022
$8.86B(+1.4%)
$1.47B(-22.4%)
$8.86B(-10.0%)
Sep 2022
-
$1.90B(-23.6%)
$9.85B(-6.9%)
Jun 2022
-
$2.48B(-17.4%)
$10.57B(+10.5%)
Mar 2022
-
$3.01B(+22.3%)
$9.57B(+9.5%)
Dec 2021
$8.74B(+58.6%)
$2.46B(-6.4%)
$8.74B(-0.7%)
Sep 2021
-
$2.63B(+77.2%)
$8.81B(+13.8%)
Jun 2021
-
$1.48B(-32.0%)
$7.74B(+11.9%)
Mar 2021
-
$2.18B(-13.7%)
$6.92B(+25.5%)
Dec 2020
$5.51B(+16.2%)
$2.52B(+62.0%)
$5.51B(+25.5%)
Sep 2020
-
$1.56B(+136.1%)
$4.39B(+7.0%)
Jun 2020
-
$660.00M(-14.5%)
$4.11B(-12.9%)
Mar 2020
-
$772.00M(-45.0%)
$4.72B(-0.7%)
Dec 2019
$4.75B(+28.3%)
$1.40B(+10.6%)
$4.75B(+6.1%)
Sep 2019
-
$1.27B(0.0%)
$4.48B(+8.5%)
Jun 2019
-
$1.27B(+58.2%)
$4.13B(+7.4%)
Mar 2019
-
$803.00M(-29.1%)
$3.84B(+3.9%)
Dec 2018
$3.70B(+18.0%)
$1.13B(+23.0%)
$3.70B(+9.2%)
Sep 2018
-
$921.00M(-6.7%)
$3.39B(+2.3%)
Jun 2018
-
$987.00M(+50.0%)
$3.31B(+16.9%)
Mar 2018
-
$658.00M(-19.8%)
$2.83B(-9.7%)
Dec 2017
$3.13B(+70.0%)
$820.00M(-2.8%)
$3.13B(-6.2%)
Sep 2017
-
$844.00M(+65.8%)
$3.34B(+37.2%)
Jun 2017
-
$509.00M(-47.1%)
$2.44B(-11.3%)
Mar 2017
-
$962.00M(-6.4%)
$2.75B(+48.9%)
Dec 2016
$1.84B(-44.9%)
$1.03B(-1758.1%)
$1.84B(+9.3%)
Sep 2016
-
-$62.00M(-107.6%)
$1.69B(-32.6%)
Jun 2016
-
$818.00M(+1263.3%)
$2.50B(-7.8%)
Mar 2016
-
$60.00M(-93.1%)
$2.72B(-18.8%)
Dec 2015
$3.35B(+25.4%)
$871.00M(+15.4%)
$3.35B(+0.7%)
Sep 2015
-
$755.00M(-26.7%)
$3.32B(+0.2%)
Jun 2015
-
$1.03B(+49.3%)
$3.32B(+11.3%)
Mar 2015
-
$690.00M(-18.5%)
$2.98B(+11.7%)
Dec 2014
$2.67B(+22.0%)
$847.00M(+12.9%)
$2.67B(+8.4%)
Sep 2014
-
$750.00M(+8.1%)
$2.46B(+10.4%)
Jun 2014
-
$694.00M(+84.1%)
$2.23B(+2.4%)
Mar 2014
-
$377.00M(-41.2%)
$2.18B(-9.1%)
Dec 2013
$2.19B(+2086.0%)
$641.00M(+23.7%)
$2.40B(+970.5%)
Sep 2013
-
$518.00M(-19.2%)
$223.72M(+151.2%)
Jun 2013
-
$641.00M(+7.7%)
$89.06M(+46.4%)
Mar 2013
-
$595.00M(-138.9%)
$60.85M(+438.1%)
Dec 2012
$100.00M(-93.7%)
-$1.53B(-499.2%)
$11.31M(-102.2%)
Sep 2012
-
$383.35M(-37.4%)
-$512.40M(+89.9%)
Jun 2012
-
$612.79M(+12.3%)
-$269.81M(-129.1%)
Mar 2012
-
$545.46M(-126.6%)
$926.08M(-41.9%)
Dec 2011
$1.59B(-74.5%)
-$2.05B(-428.1%)
$1.59B(-71.4%)
Sep 2011
-
$625.93M(-65.4%)
$5.57B(-9.5%)
Jun 2011
-
$1.81B(+48.9%)
$6.16B(+1.9%)
Mar 2011
-
$1.21B(-36.7%)
$6.04B(-3.6%)
Dec 2010
$6.27B(-18.8%)
$1.92B(+58.2%)
$6.27B(-0.4%)
Sep 2010
-
$1.21B(-28.3%)
$6.29B(-11.2%)
Jun 2010
-
$1.69B(+17.5%)
$7.09B(-0.2%)
Mar 2010
-
$1.44B(-26.0%)
$7.10B(-8.0%)
Dec 2009
$7.71B(+20.8%)
$1.95B(-3.0%)
$7.71B(-4.8%)
Sep 2009
-
$2.01B(+17.7%)
$8.10B(+8.1%)
Jun 2009
-
$1.70B(-17.1%)
$7.49B(-0.9%)
Mar 2009
-
$2.06B(-12.0%)
$7.56B(+11.1%)
Dec 2008
$6.38B(+39.4%)
$2.34B(+67.3%)
$6.81B(+13.7%)
Sep 2008
-
$1.40B(-21.3%)
$5.99B(+8.5%)
Jun 2008
-
$1.77B(+36.1%)
$5.52B(+11.9%)
Mar 2008
-
$1.30B(-14.1%)
$4.93B(+7.8%)
Dec 2007
$4.58B(+12.9%)
$1.52B(+63.8%)
$4.58B(+11.3%)
Sep 2007
-
$926.55M(-21.9%)
$4.11B(+0.6%)
Jun 2007
-
$1.19B(+25.2%)
$4.09B(+18.7%)
Mar 2007
-
$947.63M(-10.0%)
$3.45B(-2.7%)
Dec 2006
$4.06B(-7.4%)
$1.05B(+16.6%)
$3.54B(-6.5%)
Sep 2006
-
$903.17M(+66.4%)
$3.79B(+1.5%)
Jun 2006
-
$542.78M(-47.9%)
$3.73B(-12.9%)
Mar 2006
-
$1.04B(-19.8%)
$4.29B(-2.1%)
Dec 2005
$4.38B(+4.8%)
$1.30B(+53.4%)
$4.38B(+2.9%)
Sep 2005
-
$847.81M(-22.6%)
$4.25B(-4.1%)
Jun 2005
-
$1.09B(-3.6%)
$4.44B(+3.1%)
Mar 2005
-
$1.14B(-3.4%)
$4.30B(+3.0%)
Dec 2004
$4.18B
$1.18B(+14.1%)
$4.18B(+3.3%)
Sep 2004
-
$1.03B(+7.3%)
$4.04B(+3.8%)
DateAnnualQuarterlyTTM
Jun 2004
-
$960.46M(-4.9%)
$3.89B(+21.6%)
Mar 2004
-
$1.01B(-3.1%)
$3.20B(+0.9%)
Dec 2003
$3.07B(-5.7%)
$1.04B(+18.1%)
$3.17B(+20.1%)
Sep 2003
-
$882.01M(+229.8%)
$2.64B(-1.2%)
Jun 2003
-
$267.42M(-72.7%)
$2.67B(-16.4%)
Mar 2003
-
$980.49M(+92.0%)
$3.20B(-2.0%)
Dec 2002
$3.26B(+1.1%)
$510.60M(-44.1%)
$3.26B(-9.6%)
Sep 2002
-
$913.40M(+15.5%)
$3.61B(+4.9%)
Jun 2002
-
$790.80M(-24.3%)
$3.44B(+0.6%)
Mar 2002
-
$1.04B(+21.8%)
$3.42B(+6.0%)
Dec 2001
$3.22B(-5.2%)
$858.02M(+15.2%)
$3.22B(-2.0%)
Sep 2001
-
$744.63M(-3.4%)
$3.29B(-1.2%)
Jun 2001
-
$770.51M(-9.5%)
$3.33B(-2.1%)
Mar 2001
-
$851.27M(-7.8%)
$3.40B(-0.0%)
Dec 2000
$3.40B(+8.0%)
$922.92M(+17.6%)
$3.40B(+2.7%)
Sep 2000
-
$784.72M(-6.8%)
$3.31B(+6.6%)
Jun 2000
-
$841.57M(-1.2%)
$3.10B(+0.3%)
Mar 2000
-
$851.36M(+2.2%)
$3.10B(-1.7%)
Dec 1999
$3.15B(+1.0%)
$833.05M(+44.0%)
$3.15B(+0.1%)
Sep 1999
-
$578.47M(-30.5%)
$3.15B(-3.8%)
Jun 1999
-
$832.41M(-8.1%)
$3.27B(+1.6%)
Mar 1999
-
$905.33M(+8.9%)
$3.22B(+3.3%)
Dec 1998
$3.12B(+10.0%)
$831.40M(+18.2%)
$3.12B(+2.2%)
Sep 1998
-
$703.50M(-9.8%)
$3.05B(+2.8%)
Jun 1998
-
$779.69M(-2.9%)
$2.97B(+2.3%)
Mar 1998
-
$802.80M(+5.0%)
$2.90B(+2.4%)
Dec 1997
$2.83B(+8.3%)
$764.30M(+23.0%)
$2.83B(+1.7%)
Sep 1997
-
$621.50M(-12.7%)
$2.79B(+1.7%)
Jun 1997
-
$712.21M(-3.2%)
$2.74B(+2.3%)
Mar 1997
-
$735.81M(+2.8%)
$2.68B(+2.3%)
Dec 1996
$2.62B(+9.8%)
$715.81M(+24.6%)
$2.62B(+2.3%)
Sep 1996
-
$574.71M(-11.8%)
$2.56B(+1.3%)
Jun 1996
-
$651.60M(-3.5%)
$2.53B(+2.3%)
Mar 1996
-
$675.00M(+2.9%)
$2.47B(+3.6%)
Dec 1995
$2.38B(+11.1%)
$655.86M(+20.8%)
$2.38B(+2.9%)
Sep 1995
-
$542.92M(-8.7%)
$2.32B(+2.6%)
Jun 1995
-
$594.65M(+0.9%)
$2.26B(+2.3%)
Mar 1995
-
$589.48M(-0.0%)
$2.21B(+2.9%)
Dec 1994
$2.14B(+11.4%)
$589.70M(+21.8%)
$2.14B(-1.1%)
Sep 1994
-
$484.03M(-10.9%)
$2.17B(+1.8%)
Jun 1994
-
$543.49M(+3.1%)
$2.13B(+6.2%)
Mar 1994
-
$527.00M(-14.2%)
$2.01B(+4.2%)
Dec 1993
$1.92B(+26.1%)
$614.07M(+37.9%)
$1.92B(+8.2%)
Sep 1993
-
$445.20M(+6.2%)
$1.78B(+0.1%)
Jun 1993
-
$419.20M(-5.9%)
$1.78B(+14.0%)
Mar 1993
-
$445.50M(-4.9%)
$1.56B(+2.1%)
Dec 1992
$1.53B(-2.0%)
$468.50M(+5.7%)
$1.53B(+0.5%)
Sep 1992
-
$443.20M(+120.3%)
$1.52B(+6.3%)
Jun 1992
-
$201.20M(-51.3%)
$1.43B(-10.7%)
Mar 1992
-
$413.20M(-10.4%)
$1.60B(+2.7%)
Dec 1991
$1.56B(+10.7%)
$461.40M(+30.9%)
$1.56B(+3.9%)
Sep 1991
-
$352.60M(-5.2%)
$1.50B(+2.0%)
Jun 1991
-
$372.00M(+0.3%)
$1.47B(+1.3%)
Mar 1991
-
$371.00M(-7.9%)
$1.45B(+3.1%)
Dec 1990
$1.41B(+15.1%)
$402.90M(+24.9%)
$1.41B(-182.7%)
Sep 1990
-
$322.60M(-8.5%)
-$1.70B(+138.7%)
Jun 1990
-
$352.70M(+7.6%)
-$712.20M(-380.8%)
Mar 1990
-
$327.90M(-112.1%)
$253.60M(-79.2%)
Dec 1989
$1.22B(+10.8%)
-$2.70B(-306.3%)
$1.22B(-12.5%)
Sep 1989
-
$1.31B(-0.6%)
$1.40B(+7.5%)
Jun 1989
-
$1.32B(+1.8%)
$1.30B(+7.3%)
Mar 1989
-
$1.30B(-151.2%)
$1.21B(+9.7%)
Dec 1988
$1.10B(+9.6%)
-$2.53B(-308.6%)
$1.10B(-25.7%)
Sep 1988
-
$1.21B(-1.4%)
$1.48B(+8.9%)
Jun 1988
-
$1.23B(+3.5%)
$1.36B(+14.3%)
Mar 1988
-
$1.19B(-155.3%)
$1.19B(+18.4%)
Dec 1987
$1.01B(+14.5%)
-$2.15B(-297.0%)
$1.01B(-21.9%)
Sep 1987
-
$1.09B(+2.9%)
$1.29B(+13.2%)
Jun 1987
-
$1.06B(+5.5%)
$1.14B(+11.9%)
Mar 1987
-
$1.00B(-153.8%)
$1.02B(+15.7%)
Dec 1986
$878.60M(+19.2%)
-$1.87B(-298.3%)
$878.60M(-18.3%)
Sep 1986
-
$940.90M(+0.3%)
$1.08B(+12.3%)
Jun 1986
-
$938.00M(+8.4%)
$957.40M(+13.1%)
Mar 1986
-
$865.50M(-151.9%)
$846.40M(+14.8%)
Dec 1985
$737.10M(+8.9%)
-$1.67B(-302.8%)
$737.10M(-11.1%)
Sep 1985
-
$822.70M(-0.5%)
$828.90M(+12.4%)
Jun 1985
-
$827.00M(+9.4%)
$737.40M(+3.6%)
Mar 1985
-
$756.20M(-148.0%)
$711.80M(+5.2%)
Dec 1984
$676.60M
-$1.58B(-315.7%)
$676.70M(-70.0%)
Sep 1984
-
$731.20M(-8.8%)
$2.25B(+48.0%)
Jun 1984
-
$801.40M(+11.1%)
$1.52B(+111.1%)
Mar 1984
-
$721.10M
$721.10M

FAQ

  • What is Abbott Laboratories annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Abbott Laboratories?
  • What is Abbott Laboratories annual EBIT year-on-year change?
  • What is Abbott Laboratories quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Abbott Laboratories?
  • What is Abbott Laboratories quarterly EBIT year-on-year change?
  • What is Abbott Laboratories TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Abbott Laboratories?
  • What is Abbott Laboratories TTM EBIT year-on-year change?

What is Abbott Laboratories annual earnings before interest & taxes?

The current annual EBIT of ABT is $7.23B

What is the all time high annual EBIT for Abbott Laboratories?

Abbott Laboratories all-time high annual earnings before interest & taxes is $8.86B

What is Abbott Laboratories annual EBIT year-on-year change?

Over the past year, ABT annual earnings before interest & taxes has changed by -$73.00M (-1.00%)

What is Abbott Laboratories quarterly earnings before interest & taxes?

The current quarterly EBIT of ABT is $2.08B

What is the all time high quarterly EBIT for Abbott Laboratories?

Abbott Laboratories all-time high quarterly earnings before interest & taxes is $3.01B

What is Abbott Laboratories quarterly EBIT year-on-year change?

Over the past year, ABT quarterly earnings before interest & taxes has changed by +$121.00M (+6.19%)

What is Abbott Laboratories TTM earnings before interest & taxes?

The current TTM EBIT of ABT is $7.48B

What is the all time high TTM EBIT for Abbott Laboratories?

Abbott Laboratories all-time high TTM earnings before interest & taxes is $10.57B

What is Abbott Laboratories TTM EBIT year-on-year change?

Over the past year, ABT TTM earnings before interest & taxes has changed by +$180.00M (+2.47%)
On this page